The Winter 2013 issue of The Marker is here to keep you abreast of the latest news from the PROOF Centre.
Click here to read about our recent collaborations and other exciting activities we have been involved with over the …
Welcome Aboard Dr. David Brener!
The PROOF Centre welcomes Dr. David Brener as its new Chief Business Development Officer.
Dr. Brener is a leader in the identification, development, management and delivery of innovative vehicles enabling R&D commercialization and knowledge translation in both the private and …
Working with AllerGen NCE to Speed Up Clinical Trials for Allergic Asthma
Two Networks of Centres of Excellence (NCEs), the Centre of Excellence for the Prevention of Organ Failure (PROOF Centre) and AllerGen NCE (Allergy, Genes and Environment Network of Centres of Excellence), are working together to develop blood tests that will …
Technology at the Fingertips for Better Patient Care: The PROOF Centre and IO Informatics to Develop a Web-Based App
The PROOF Centre and IO Informatics are putting their heads together to develop new tools for clinicians to address chronic heart, lung and kidney disease.
The collaboration brings together the PROOF Centre’s award-winning science and IO Informatics’ leading software and …
One Step Closer to the Clinic: PROOF Centre and HTG Molecular Diagnostics Partner to Commercialize COPD Test
The PROOF Centre has granted HTG Molecular Diagnostics exclusive rights to commercialize PROOF Centre-developed gene expression blood tests for the prognosis of patients with Chronic Obstructive Pulmonary Disease (COPD) who will experience frequent exacerbations (“lung attacks”).
The PROOF Centre – …